OUP Management »

Ikena Oncology shares owned by OUP Management

Quarter-by-quarter ownership of Ikena Oncology (IKNA) shares owned by OUP Management from 13F filings

Historical chart of OUP Management investment in Ikena Oncology

Tip: Access up to 7 years of quarterly data

All positions including Ikena Oncology held by OUP Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ikena Oncology by OUP Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $116k 27k 4.33

More positions owned by OUP Management

Centessa Pharmaceuticals Sponsored ADS (CNTA)
Aerovate Therapeutics Common Stock (AVTE)
Cyteir Therapeutics Common Stock
PMV Pharmaceuticals Common Stock (PMVP)
Graphite Bio Common Stock
Selecta Biosciences Common Stock
Vor Biopharma Common Stock (VOR)
eFFECTOR Therapeutics Common Stock
Precision BioSciences Common Stock
Spero Therapeutics Common Stock (SPRO)
Ikena Oncology Common Stock (IKNA)
Homology Medicines Common Stock

View all positions for OUP Management

Top funds holding Ikena Oncology

Atlas Venture Life Science Advisors
BVF
Blue Owl Capital Holdings
OrbiMed Advisors
Omega Fund Management
Vanguard Group
Adage Capital Partners GP
BML Capital Management
NEA Management Company
Peapod Lane Capital
Acuitas Investments
Renaissance Technologies
Jacobs Levy Equity Management
Sofinnova Ventures
BlackRock

View all funds holding Ikena Oncology